Device Trial Radar · NCT07938086
Automated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk Test
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
24
Planned (sponsor's estimate)
Start
Apr 15, 2026
Primary completion
Dec 20, 2026
Study completion Dec 20, 2026
Sponsor
- Lead sponsor
- Aether Tech S.L.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Hospital Universitario Fundación Jiménez Díaz
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates EMILY.AI, an investigational (non-CE-marked) smart oxygen valve that automatically adjusts the oxygen flow delivered to a patient. Adults with chronic respiratory disease who need oxygen during exertion perform two six-minute walk tests on the same day, 30 minutes apart: one with oxygen adjusted automatically by EMILY.AI and one with a fixed oxygen flow delivered through the same device. The order is randomized and participants do not know which test uses automatic titration. The study compares the time spent within the target saturation range, desaturation, oxygen use, walking distance, breathlessness and participant preference between the two tests. This substudy is part of clinical investigation FJD-EMILY-23-02, whose other substudies are registered in separate records.
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Diseases
- Pulmonary Hypertension
- Chronic Respiratory Failure
Interventions
EMILY.AI automatic oxygen titrationDevice
Investigational smart oxygen valve with rule-based algorithm that adjusts oxygen flow every second from pulse-oximetry SpO2, heart rate and respiratory rate during walking and recovery.
Fixed-flow oxygenOther
Standard care: constant oxygen flow set by the physician, delivered through the EMILY.AI device in fixed mode so that the participant cannot distinguish it from automatic titration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of time with SpO2 within the target rangeTime frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hospital Universitario Fundación Jiménez Díaz
Madrid, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.